Skip to main content

Published locations for HER2+ early BC: Atezolizumab fails to improve pCR rate in phase 3

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. HER2+ early BC: Atezolizumab fails to improve pCR rate in phase 3

User login

  • Reset your password
  • /content/her2-early-bc-atezolizumab-fails-improve-pcr-rate-phase-3
  • /hematology-oncology/article/256512/breast-cancer/her2-early-bc-atezolizumab-fails-improve-pcr-rate
  • /breast-cancer-icymi/article/256512/breast-cancer/her2-early-bc-atezolizumab-fails-improve-pcr-rate